Lovastatin increases the risk of myopathy and:
A) hyperglycemia
B) hyperlipidemia
C) rhabdomyolysis
D) hypertension
C) rhabdomyolysis
Lovastatin increases the risk of myopathy and rhabdomyolysis. It may also increase repaglinide levels and duration of action. Lovastatin is sold under the trade names AltoprevĀ® and MevacorĀ®.
Health Professions
You might also like to view...
Which of the following NIV settings produces the greatest tidal volume, with all other variables being equal (i.e., airway resistance and lung compliance)?
a. IPAP = 20 cm H2O; EPAP = 8 cm H2O b. IPAP = 15 cm H2O; EPAP = 5 cm H2O c. IPAP = 12 cm H2O; EPAP = 6 cm H2O d. IPAP = 18 cm H2O; EPAP = 4 cm H2O
Health Professions
Detachment at left femoral region, open approach
A) 0Y630ZZ B) 0Y640ZZ C) 0Y670ZZ D) 0Y680ZZ
Health Professions